evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract
18110,GENE_SUMMARY,,"CD79A encodes a surface membrane protein that complexes with CD79B to form a heterodimer important for signaling from B-lymphocytes. Germline mutations of CD79A are linked to agammaglobulinemia, while somatic mutations have been identified in diffuse large B-cell lymphoma.",,2017-01-16,,973,CD79A,CD79a molecule,False,ENST00000221972,NM_001783.3,IGA,MB-1,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18111,GENE_BACKGROUND,,"CD79A is a surface immunoglobulin protein that forms a complex with CD79B and composes part of the B-cell receptor (BCR) (PMID: 1439759). CD79A is expressed from an early stage of B-cell development until the final stage of maturation prior to differentiation into plasma cells (PMID: 21841126, 24146823). The CD79A/CD79B complex is important for transmitting signals generated by antigen binding to the BCR into the cell to support B-cell maturation and survival (PMID: 15186779). Following BCR-ligand interaction, CD79A and CD79B are phosphorylated and activated by SRC family kinases leading to activation of downstream oncogenic signaling cascades that affect B-cell maturation (PMID: 17114463, 15699130, 20940318, 22078222,11514602). Activating mutations in CD79A have been identified in diffuse large B-cell lymphoma, particularly the activated B-cell-like subtype (PMID: 20054396), suggesting that CD79A acts as an oncogene. Such aberrations result in increased BCR signaling and ligand-independent clustering of BCRs, resulting in enhanced B-cell survival and differentiation. Antibody-drug conjugates targeting CD79A/B and inhibitors targeting SRC activity, such as dasatinib, can reduce BCR signaling (PMID: 17374736, 20054396).",,2017-09-12,,973,CD79A,CD79a molecule,False,ENST00000221972,NM_001783.3,IGA,MB-1,False,17114463,Analysis of the individual contributions of Igalpha (CD79a)- and Igbeta (CD79b)-mediated tonic signaling for bone marrow B cell development and peripheral B cell maturation.,"Journal of immunology (Baltimore, Md. : 1950)",2017-12-01T20:06:00,177,11,7913-22,Fuentes-Panan√° EM et al,,,2017-12-01T19:50:00,,1439759,The B cell antigen receptor complex: association of Ig-alpha and Ig-beta with distinct cytoplasmic effectors.,"Science (New York, N.Y.)",0001-10-02,258,5079,123-6,Clark MR et al,,,0001-10-02,,11514602,"Interference with immunoglobulin (Ig)alpha immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igbeta cytoplasmic tail.",The Journal of experimental medicine,2018-08-20T20:01:00,194,4,455-69,Kraus M et al,,,0001-08-20,,17374736,Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma.,Blood,2018-07-15T20:07:00,110,2,616-23,Polson AG et al,,,0001-07-15,,20940318,Syk is a dual-specificity kinase that self-regulates the signal output from the B-cell antigen receptor.,Proceedings of the National Academy of Sciences of the United States of America,2018-10-26T20:10:00,107,43,18563-8,Heizmann B et al,doi: 10.1073/pnas.1009048107,,0001-10-26,,20054396,Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.,Nature,2018-01-07T20:10:00,463,7277,88-92,Davis RE et al,doi: 10.1038/nature08638,,0001-01-07,,15699130,Dual requirement for the Ig alpha immunoreceptor tyrosine-based activation motif (ITAM) and a conserved non-Ig alpha ITAM tyrosine in supporting Ig alpha beta-mediated B cell development.,"Journal of immunology (Baltimore, Md. : 1950)",2018-02-15T20:05:00,174,4,2012-20,Pike KA et al,,,2018-02-15T19:50:00,,22078222,Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy.,Immunity,2017-11-23T20:11:00,35,5,746-56,O'Neill SK et al,doi: 10.1016/j.immuni.2011.10.011,,0001-11-23,,21841126,Cytoplasmic Ig alpha serine/threonines fine-tune Ig alpha tyrosine phosphorylation and limit bone marrow plasma cell formation.,"Journal of immunology (Baltimore, Md. : 1950)",2018-09-15T20:11:00,187,6,2853-8,Patterson HC et al,doi: 10.4049/jimmunol.1101143,,2018-09-15T19:50:00,,15186779,Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer.,Cell,2018-06-11T20:04:00,117,6,787-800,Kraus M et al,,,2018-06-11T08:00:00,,24146823,Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects.,PloS one,2013,8,10,e76115,Luger D et al,doi: 10.1371/journal.pone.0076115,,Luger D et al. PloS one. 2013;8(10)e76115.,
